NASDAQ:CMLF

CM Life Sciences Stock Forecast, Price & News

$16.41

+0.40 (+2.50 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$13.67

Now: $16.41▼

$16.58

50-Day Range N/A

52-Week Range

$9.66

Now: $16.41▼

$27.18

Volume3.40 million shs

Average Volume2.12 million shs

Market Capitalization$908.20 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

Headlines

CM LIFE SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CM Life Sciences - CMLF
February 24, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Shell Companies

Sub-IndustryN/A

SectorFinancial Services

Current SymbolNASDAQ:CMLF

Previous Symbol

CUSIPN/A

CIKN/A

Webcmlifesciencesspac.com

Phone212 474 6745

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares55,344,000

Market Cap$908.20 million

Next Earnings DateN/A

OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Financial Services Sector

624th out of 658 stocks

Shell Companies Industry

226th out of 276 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for CM Life Sciences.

0.0 Community Rank

Outperform Votes
CM Life Sciences has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CM Life Sciences has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about CM Life Sciences and other stocks. Vote “Outperform” if you believe CMLF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CMLF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CM Life Sciences does not currently pay a dividend.
Dividend Growth
CM Life Sciences does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CM Life Sciences insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$16.41

+0.40 (+2.50 %)

(As of 03/5/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CMLF News and Ratings via Email

Sign-up to receive the latest news and ratings for CMLF and its competitors with MarketBeat's FREE daily newsletter.

CM Life Sciences (NASDAQ:CMLF) Frequently Asked Questions

What stocks does MarketBeat like better than CM Life Sciences?

Wall Street analysts have given CM Life Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CM Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting CM Life Sciences?

CM Life Sciences saw a increase in short interest in February. As of February 12th, there was short interest totaling 435,100 shares, an increase of 60.8% from the January 28th total of 270,600 shares. Based on an average daily volume of 1,210,000 shares, the days-to-cover ratio is presently 0.4 days.
View CM Life Sciences' Short Interest.

Who are CM Life Sciences' key executives?

CM Life Sciences' management team includes the following people:

Mr. Eli Decatur Casdin, CEO & Director
Mr. Brian Emes, CFO & Sec. (Age 38)
Dr. Shaun Kevin Rodriguez, Chief Strategy Officer (Age 43)

Who are some of CM Life Sciences' key competitors?

Some companies that are related to CM Life Sciences include Chargepoint (CHPT), Ajax I (AJAX), Bridgetown (BTWN), TPG Pace Beneficial Finance (TPGY), Bluescape Opportunities Acquisition (BOAC), Horizon Acquisition Co. II (HZON), Vy Global Growth (VYGG), Atlas Crest Investment (ACIC), Landcadia Holdings III (LCY), BowX Acquisition (BOWX), Vesper Healthcare Acquisition (VSPR), TPG Pace Tech Opportunities (PACE), Health Assurance Acquisition (HAAC), Altimeter Growth Corp. 2 (AGCB) and CF Finance Acquisition Corp. II (CFII).
View all of CMLF's competitors.

What is CM Life Sciences' stock symbol?

CM Life Sciences trades on the NASDAQ under the ticker symbol "CMLF."

Who are CM Life Sciences' major shareholders?

CM Life Sciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.02%).

Which major investors are buying CM Life Sciences stock?

CMLF stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC.

How do I buy shares of CM Life Sciences?

Shares of CMLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CM Life Sciences' stock price today?

One share of CMLF stock can currently be purchased for approximately $16.41.

How much money does CM Life Sciences make?

CM Life Sciences has a market capitalization of $908.20 million.

What is CM Life Sciences' official website?

The official website for CM Life Sciences is cmlifesciencesspac.com.

How can I contact CM Life Sciences?

The company can be reached via phone at 212 474 6745.

This page was last updated on 3/6/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here